Breaking Barriers in Behavioral Change: The Potential of AI-Driven Motivational Interviewing.

Abstract

Patient outcomes in ophthalmology are greatly influenced by adherence and patient participation, which can be particularly challenging in diseases like glaucoma where medication regimens can be complex. A well-studied and evidence-based intervention for behavioral change is Motivational Interviewing (MI), a collaborative and patient-centered counseling approach, which has been shown to improve medication adherence in glaucoma patients. However, there are many barriers to clinicians being able to provide motivational interviewing in-office, including short visit durations within high-volume ophthalmology clinics and inadequate billing structures for counseling. Recently, Large Language Models (LLMs), a type of artificial intelligence, have advanced such that they can follow instructions and carry coherent conversations, offering novel solutions to a wide range of clinical problems. In this paper, we discuss the potential of LLMs to provide chatbot-driven MI to improve adherence in glaucoma patients, and provide an example conversation as a proof of concept. We discuss the advantages of AI-driven MI, such as demonstrated effectiveness, scalability, and accessibility. We also explore the risks and limitations, including issues of safety and privacy, as well as the factual inaccuracies and hallucinations to which LLMs are susceptible. Domain-specific training may be needed to ensure accuracy and completeness of information provided in subspecialty areas such as glaucoma. Despite the current limitations, AI-driven Motivational Interviewing has the potential to offer significant improvements in adherence, and should be further explored to maximally leverage the potential of artificial intelligence for our patients.